Research and development has been at the very heart of Crossject since the company's initial work on its innovative needle-free self-injection system ZENEO® in 1997.
For its R&D, constantly focused on innovation, Crossject has recruited and formed a team from several specialties and industries to ensure a variety of missions within the company :
• determination of patient needs,
• research on existing molecules,
• management of regulatory, medical and pharmaceutical affairs,
• identification of partners and commercial distributors, etc.